Public evidence directory

Evidence sources.

Independent scientific, regulatory, terminology and public-information resources connected to GeneDrugs research.

European and international evidence

🇪🇺 EMA — European UnionHuman medicines in the centralised EMA dataset, with reported regulatory status. This does not cover every national authorisation in Europe.🌐 Europe PMC — international literaturePublication metadata from an international collection, including labelled preprints. Shared PubMed records are combined by PubMed identifier.

Publications and genetics

PubMed / NCBIBiomedical publications and bibliographic metadata.NCBI GeneGene identifiers and public gene information.ClinVarPublic human-variant and health relationships.

Clinical research

ClinicalTrials.govPublic clinical-study records and trial metadata.

Drugs and regulation

PubChemChemical and compound information.RxNorm / RxNavNormalized drug terminology.NLM RxTermsDrug terminology and display names.openFDAPublic FDA labels, enforcement and recall data.Health Canada Drug Product DatabaseCanadian drug-product information.

Medical terminology

NLM Clinical TablesMedical conditions, synonyms, codes and procedures.MeSHNLM controlled biomedical vocabulary.MONDO Disease OntologyDisease terminology and ontology relationships.Human Phenotype OntologyStandardized phenotypic terminology.

Public background

MedlinePlusConsumer health information and coded-resource links.Wikipedia / WikimediaGeneral discovery context only—not primary medical evidence.

AI-assisted clarification

Bounded terminology assistanceUsed only to clarify unresolved language. Model output is not an independent medical evidence source or diagnosis.

External sources remain subject to their own terms, licensing and data policies. GeneDrugs does not claim ownership of third-party source data.